2024 Q1 Form 10-K Financial Statement
#000120677424000233 Filed on March 05, 2024
Income Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
Revenue | $1.164M | $4.036M | |
YoY Change | 87.14% | -3.86% | |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $1.214M | $1.206M | $4.800M |
YoY Change | 0.91% | 2.46% | 29.73% |
% of Gross Profit | |||
Operating Expenses | |||
YoY Change | |||
Operating Profit | |||
YoY Change | |||
Interest Expense | $29.72M | $99.94M | |
YoY Change | 65.97% | 398.7% | |
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $3.384M | $5.337M | $17.43M |
YoY Change | -4.38% | -24.7% | -54.28% |
Income Tax | $862.0K | $1.170M | $4.001M |
% Of Pretax Income | 25.47% | 21.92% | 22.96% |
Net Earnings | $2.522M | $4.167M | $13.43M |
YoY Change | -6.7% | -24.13% | -53.89% |
Net Earnings / Revenue | 216.67% | 332.66% | |
Basic Earnings Per Share | $0.31 | $1.67 | |
Diluted Earnings Per Share | $0.31 | $0.52 | $1.66 |
COMMON SHARES | |||
Basic Shares Outstanding | 8.156M shares | 8.089M shares | 8.047M shares |
Diluted Shares Outstanding | 8.142M shares | 8.078M shares |
Balance Sheet
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $167.3M | $156.2M | |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | |||
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $93.01M | $94.30M | $94.30M |
YoY Change | -4.91% | -4.92% | -4.92% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $12.32M | $12.20M | $12.20M |
YoY Change | 1.94% | -2.57% | -2.57% |
Total Long-Term Assets | |||
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | |||
Total Long-Term Assets | |||
Total Assets | $4.106B | $4.056B | $4.056B |
YoY Change | 4.25% | 9.85% | 9.85% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $24.30M | $24.60M | $24.60M |
YoY Change | -4.71% | -4.65% | -4.65% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $24.30M | $24.60M | $24.60M |
YoY Change | -4.71% | -4.65% | -4.65% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $36.35M | $36.32M | $36.32M |
YoY Change | 0.3% | 0.3% | 0.3% |
Other Long-Term Liabilities | $53.42M | $52.44M | $52.44M |
YoY Change | 111.35% | 0.09% | 0.09% |
Total Long-Term Liabilities | $89.77M | $88.76M | $88.76M |
YoY Change | 45.92% | 0.17% | 0.17% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $24.30M | $24.60M | $24.60M |
Total Long-Term Liabilities | $89.77M | $88.76M | $88.76M |
Total Liabilities | $3.790B | $3.743B | $3.743B |
YoY Change | 4.17% | 10.18% | 10.18% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $208.1M | $205.5M | |
YoY Change | 6.8% | 6.99% | |
Common Stock | $82.00K | $81.00K | |
YoY Change | 2.5% | 1.25% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $315.3M | $312.5M | $312.5M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $4.106B | $4.056B | $4.056B |
YoY Change | 4.25% | 9.85% | 9.85% |
Cashflow Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $2.522M | $4.167M | $13.43M |
YoY Change | -6.7% | -24.13% | -53.89% |
Depreciation, Depletion And Amortization | $1.214M | $1.206M | $4.800M |
YoY Change | 0.91% | 2.46% | 29.73% |
Cash From Operating Activities | -$2.924M | $6.863M | $17.65M |
YoY Change | -336.38% | -49.04% | -64.91% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $280.0K | $122.0K | $1.242M |
YoY Change | 55.56% | -85.05% | -91.1% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$31.94M | -$34.77M | -$377.3M |
YoY Change | -77.61% | -86.09% | -51.54% |
Cash From Investing Activities | -$32.22M | -$34.89M | -$378.6M |
YoY Change | -77.44% | -86.08% | -52.24% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $46.28M | 31.82M | $346.2M |
YoY Change | -80.95% | -87.15% | -53.59% |
NET CHANGE | |||
Cash From Operating Activities | -$2.924M | 6.863M | $17.65M |
Cash From Investing Activities | -$32.22M | -34.89M | -$378.6M |
Cash From Financing Activities | $46.28M | 31.82M | $346.2M |
Net Change In Cash | $11.14M | 3.786M | -$14.70M |
YoY Change | -89.01% | -63.13% | -501.2% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$2.924M | $6.863M | $17.65M |
Capital Expenditures | $280.0K | $122.0K | $1.242M |
Free Cash Flow | -$3.204M | $6.741M | $16.41M |
YoY Change | -403.12% | -46.72% | -54.86% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001090009 | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023 | SFST |
Net Lender And Referral Fees On Ppp Loans
NetLenderAndReferralFeesOnPppLoans
|
usd | |
CY2022 | SFST |
Net Lender And Referral Fees On Ppp Loans
NetLenderAndReferralFeesOnPppLoans
|
usd | |
CY2023 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
usd | |
CY2023 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
usd | |
CY2023 | SFST |
Real Estate Owned Expenses
RealEstateOwnedExpenses
|
usd | |
CY2022 | SFST |
Real Estate Owned Expenses
RealEstateOwnedExpenses
|
usd | |
CY2023 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
usd | |
CY2023 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
usd | |
CY2021 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
usd | |
CY2022 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
usd | |
CY2023 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
usd | |
CY2023 | SFST |
Loss On Sale Of Real Estate Owned
LossOnSaleOfRealEstateOwned
|
usd | |
CY2022 | SFST |
Loss On Sale Of Real Estate Owned
LossOnSaleOfRealEstateOwned
|
usd | |
CY2023 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
usd | |
CY2023 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
usd | |
CY2021 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
usd | |
CY2023 | us-gaap |
Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
|
usd | |
CY2022 | us-gaap |
Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
|
usd | |
CY2023 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
usd | |
CY2023 | us-gaap |
Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
|
usd | |
CY2022 | us-gaap |
Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
|
usd | |
CY2023 | SFST |
Foreclosure Of Other Real Estate
ForeclosureOfOtherRealEstate
|
usd | |
CY2022 | SFST |
Foreclosure Of Other Real Estate
ForeclosureOfOtherRealEstate
|
usd | |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
usd | |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
usd | |
CY2023 | SFST |
Current Period Gross Writeoffs2023
CurrentPeriodGrossWriteoffs2023
|
usd | |
CY2023 | SFST |
Current Period Gross Writeoffs2021
CurrentPeriodGrossWriteoffs2021
|
usd | |
CY2023 | SFST |
Current Period Gross Writeoffs2019
CurrentPeriodGrossWriteoffs2019
|
usd | |
CY2022 | SFST |
Current Period Gross Writeoffs2023
CurrentPeriodGrossWriteoffs2023
|
usd | |
CY2022 | SFST |
Current Period Gross Writeoffs2021
CurrentPeriodGrossWriteoffs2021
|
usd | |
CY2022 | SFST |
Current Period Gross Writeoffs2019
CurrentPeriodGrossWriteoffs2019
|
usd | |
CY2022 | SFST |
Current Period Gross Writeoffs Revolving Convert Term
CurrentPeriodGrossWriteoffsRevolvingConvertTerm
|
usd | |
CY2023Q4 | SFST |
Nonaccruing Td Rs
NonaccruingTDRs
|
usd | |
CY2023Q4 | SFST |
Other Real Estate Owned
OtherRealEstateOwned
|
usd | |
CY2022Q4 | SFST |
Other Real Estate Owned
OtherRealEstateOwned
|
usd | |
CY2023Q4 | us-gaap |
Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
|
usd | |
CY2022Q4 | us-gaap |
Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
|
usd | |
CY2023Q4 | SFST |
Accruing Troubled Debt Restructurings
AccruingTroubledDebtRestructurings
|
usd | |
CY2023Q4 | SFST |
Business Assets
BusinessAssets
|
usd | |
CY2023Q4 | us-gaap |
Other Loans Payable
OtherLoansPayable
|
usd | |
CY2022Q4 | SFST |
Business Assets
BusinessAssets
|
usd | |
CY2022Q4 | us-gaap |
Other Loans Payable
OtherLoansPayable
|
usd | |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
usd | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | |
CY2023 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
||
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
||
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
000-27719 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
Southern First Bancshares, Inc. | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
SC | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
58-2459561 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
6 Verdae Boulevard | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Greenville | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
SC | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
29607 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
864 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
679-9000 | |
CY2023 | dei |
Security12b Title
Security12bTitle
|
Common Stock | |
CY2023 | dei |
Trading Symbol
TradingSymbol
|
SFST | |
CY2023 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
true | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
186359362 | usd |
CY2024Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
8156109 | shares |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
149 | |
CY2023 | dei |
Auditor Name
AuditorName
|
Elliott Davis, LLC | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Greenville, South Carolina | |
CY2023Q4 | us-gaap |
Cash And Due From Banks
CashAndDueFromBanks
|
28020000 | usd |
CY2022Q4 | us-gaap |
Cash And Due From Banks
CashAndDueFromBanks
|
18788000 | usd |
CY2023Q4 | us-gaap |
Federal Funds Sold
FederalFundsSold
|
119349000 | usd |
CY2022Q4 | us-gaap |
Federal Funds Sold
FederalFundsSold
|
101277000 | usd |
CY2023Q4 | us-gaap |
Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
|
8801000 | usd |
CY2022Q4 | us-gaap |
Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
|
50809000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
|
156170000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
|
170874000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
134702000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
93347000 | usd |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-13410000 | usd |
CY2023Q4 | us-gaap |
Other Investments
OtherInvestments
|
19939000 | usd |
CY2022Q4 | us-gaap |
Other Investments
OtherInvestments
|
10833000 | usd |
CY2023Q4 | us-gaap |
Investments
Investments
|
154641000 | usd |
CY2022Q4 | us-gaap |
Investments
Investments
|
104180000 | usd |
CY2023Q4 | us-gaap |
Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
|
7194000 | usd |
CY2022Q4 | us-gaap |
Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
|
3917000 | usd |
CY2023Q4 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
3602627000 | usd |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
3273363000 | usd |
CY2023Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
40682000 | usd |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
38639000 | usd |
CY2023Q4 | us-gaap |
Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
|
3561945000 | usd |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
|
3234724000 | usd |
CY2023Q4 | us-gaap |
Bank Owned Life Insurance
BankOwnedLifeInsurance
|
52501000 | usd |
CY2022Q4 | us-gaap |
Bank Owned Life Insurance
BankOwnedLifeInsurance
|
51122000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
94301000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
99183000 | usd |
CY2023Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
12200000 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
12522000 | usd |
CY2023Q4 | us-gaap |
Other Assets
OtherAssets
|
16837000 | usd |
CY2022Q4 | us-gaap |
Other Assets
OtherAssets
|
15459000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
4055789000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
3691981000 | usd |
CY2023Q4 | us-gaap |
Deposits
Deposits
|
3379564000 | usd |
CY2022Q4 | us-gaap |
Deposits
Deposits
|
3133864000 | usd |
CY2023Q4 | SFST |
Federal Home Loan Bank Advancesand Other Borrowings Amount
FederalHomeLoanBankAdvancesandOtherBorrowingsAmount
|
275000000 | usd |
CY2022Q4 | SFST |
Federal Home Loan Bank Advancesand Other Borrowings Amount
FederalHomeLoanBankAdvancesandOtherBorrowingsAmount
|
175000000 | usd |
CY2023Q4 | us-gaap |
Junior Subordinated Notes
JuniorSubordinatedNotes
|
36322000 | usd |
CY2022Q4 | us-gaap |
Junior Subordinated Notes
JuniorSubordinatedNotes
|
36214000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
52436000 | usd |
CY2022Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
52391000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
3743322000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
3397469000 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
8088186 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
8088186 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
8011045 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
8011045 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
81000 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
80000 | usd |
CY2023Q4 | SFST |
Nonvested Restricted Stock Value
NonvestedRestrictedStockValue
|
3596000 | usd |
CY2022Q4 | SFST |
Nonvested Restricted Stock Value
NonvestedRestrictedStockValue
|
3306000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
121777000 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
119027000 | usd |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-11342000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
205547000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
192121000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
312467000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
294512000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4055789000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3691981000 | usd |
CY2023 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
166137000 | usd |
CY2022 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
114233000 | usd |
CY2021 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
91599000 | usd |
CY2023 | us-gaap |
Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
|
4463000 | usd |
CY2022 | us-gaap |
Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
|
1990000 | usd |
CY2021 | us-gaap |
Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
|
1335000 | usd |
CY2023 | us-gaap |
Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
|
6998000 | usd |
CY2022 | us-gaap |
Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
|
1439000 | usd |
CY2021 | us-gaap |
Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
|
233000 | usd |
CY2023 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
177598000 | usd |
CY2022 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
117662000 | usd |
CY2021 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
93167000 | usd |
CY2023 | us-gaap |
Interest Expense Deposits
InterestExpenseDeposits
|
91373000 | usd |
CY2022 | us-gaap |
Interest Expense Deposits
InterestExpenseDeposits
|
18102000 | usd |
CY2021 | us-gaap |
Interest Expense Deposits
InterestExpenseDeposits
|
3909000 | usd |
CY2023 | us-gaap |
Interest Expense Borrowings
InterestExpenseBorrowings
|
8571000 | usd |
CY2022 | us-gaap |
Interest Expense Borrowings
InterestExpenseBorrowings
|
1939000 | usd |
CY2021 | us-gaap |
Interest Expense Borrowings
InterestExpenseBorrowings
|
1526000 | usd |
CY2023 | us-gaap |
Interest Expense
InterestExpense
|
99944000 | usd |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
20041000 | usd |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
5435000 | usd |
CY2023 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
77654000 | usd |
CY2022 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
97621000 | usd |
CY2021 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
87732000 | usd |
CY2023 | us-gaap |
Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
|
1260000 | usd |
CY2022 | us-gaap |
Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
|
6155000 | usd |
CY2021 | us-gaap |
Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
|
-12400000 | usd |
CY2023 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
76394000 | usd |
CY2022 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
91466000 | usd |
CY2021 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
100132000 | usd |
CY2023 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
4036000 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
4198000 | usd |
CY2021 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
11376000 | usd |
CY2023 | SFST |
Service Fees On Deposit Accounts
ServiceFeesOnDepositAccounts
|
1382000 | usd |
CY2022 | SFST |
Service Fees On Deposit Accounts
ServiceFeesOnDepositAccounts
|
1265000 | usd |
CY2021 | SFST |
Service Fees On Deposit Accounts
ServiceFeesOnDepositAccounts
|
1174000 | usd |
CY2023 | SFST |
Product Or Service On Debit Card
ProductOrServiceOnDebitCard
|
2245000 | usd |
CY2022 | SFST |
Product Or Service On Debit Card
ProductOrServiceOnDebitCard
|
2163000 | usd |
CY2021 | SFST |
Product Or Service On Debit Card
ProductOrServiceOnDebitCard
|
2037000 | usd |
CY2023 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
1379000 | usd |
CY2022 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
1289000 | usd |
CY2021 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
1231000 | usd |
CY2021 | SFST |
Net Lender And Referral Fees On Ppp Loans
NetLenderAndReferralFeesOnPppLoans
|
268000 | usd |
CY2022 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
-394000 | usd |
CY2021 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
10000 | usd |
CY2022 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
12000 | usd |
CY2021 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
-3000 | usd |
CY2023 | us-gaap |
Noninterest Income Other
NoninterestIncomeOther
|
818000 | usd |
CY2022 | us-gaap |
Noninterest Income Other
NoninterestIncomeOther
|
1047000 | usd |
CY2021 | us-gaap |
Noninterest Income Other
NoninterestIncomeOther
|
1008000 | usd |
CY2023 | us-gaap |
Noninterest Income
NoninterestIncome
|
9860000 | usd |
CY2022 | us-gaap |
Noninterest Income
NoninterestIncome
|
9580000 | usd |
CY2021 | us-gaap |
Noninterest Income
NoninterestIncome
|
17101000 | usd |
CY2023 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
40275000 | usd |
CY2022 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
38790000 | usd |
CY2021 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
36103000 | usd |
CY2023 | us-gaap |
Occupancy Net
OccupancyNet
|
10255000 | usd |
CY2022 | us-gaap |
Occupancy Net
OccupancyNet
|
9105000 | usd |
CY2021 | us-gaap |
Occupancy Net
OccupancyNet
|
6956000 | usd |
CY2021 | SFST |
Real Estate Owned Expenses
RealEstateOwnedExpenses
|
385000 | usd |
CY2023 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
7078000 | usd |
CY2022 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
6112000 | usd |
CY2021 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
5468000 | usd |
CY2023 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
3766000 | usd |
CY2022 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
1686000 | usd |
CY2021 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
1149000 | usd |
CY2023 | us-gaap |
Professional Fees
ProfessionalFees
|
2496000 | usd |
CY2022 | us-gaap |
Professional Fees
ProfessionalFees
|
2635000 | usd |
CY2021 | us-gaap |
Professional Fees
ProfessionalFees
|
2589000 | usd |
CY2023 | us-gaap |
Marketing Expense
MarketingExpense
|
1357000 | usd |
CY2022 | us-gaap |
Marketing Expense
MarketingExpense
|
1216000 | usd |
CY2021 | us-gaap |
Marketing Expense
MarketingExpense
|
905000 | usd |
CY2023 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
3600000 | usd |
CY2022 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
3389000 | usd |
CY2021 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
2875000 | usd |
CY2023 | us-gaap |
Noninterest Expense
NoninterestExpense
|
68827000 | usd |
CY2022 | us-gaap |
Noninterest Expense
NoninterestExpense
|
62933000 | usd |
CY2021 | us-gaap |
Noninterest Expense
NoninterestExpense
|
56430000 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
17427000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
38113000 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
60803000 | usd |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4001000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8998000 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
14092000 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
13426000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
29115000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
46711000 | usd |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.67 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
3.66 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
5.96 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.66 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
3.61 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
5.85 | |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
8046633 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7958294 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7843692 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
8078454 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
8071690 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7988980 | shares |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
13426000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
29115000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
46711000 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
2620000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-16027000 | usd |
CY2021 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-2232000 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
552000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
-3367000 | usd |
CY2021 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
-467000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
12000 | usd |
CY2021 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
-3000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
2000 | usd |
CY2021 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
-1000 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
2068000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-12670000 | usd |
CY2021 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-1763000 | usd |
CY2023 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
15494000 | usd |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
16445000 | usd |
CY2021 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
44948000 | usd |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
228294000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
46711000 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
3012000 | usd |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
499000 | usd |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1148000 | usd |
CY2021 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-1763000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
277901000 | usd |
CY2022 | SFST |
Adoption Of Asu201613
AdoptionOfASU201613
|
-2765000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
29115000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
905000 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
1099000 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
927000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-12670000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
294512000 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
13426000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
518000 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
1415000 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
528000 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
2068000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
312467000 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
13426000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
29115000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
46711000 | usd |
CY2023 | us-gaap |
Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
|
1260000 | usd |
CY2022 | us-gaap |
Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
|
6155000 | usd |
CY2021 | us-gaap |
Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
|
-12400000 | usd |
CY2023 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
4816000 | usd |
CY2022 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
3698000 | usd |
CY2021 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
2319000 | usd |
CY2023 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-61000 | usd |
CY2022 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-694000 | usd |
CY2021 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-935000 | usd |
CY2021 | SFST |
Loss On Sale Of Real Estate Owned
LossOnSaleOfRealEstateOwned
|
376000 | usd |
CY2022 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
12000 | usd |
CY2021 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
-3000 | usd |
CY2022 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-394000 | usd |
CY2021 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
10000 | usd |
CY2023 | SFST |
Operating Lease Payment
OperatingLeasePayment
|
233000 | usd |
CY2022 | SFST |
Operating Lease Payment
OperatingLeasePayment
|
872000 | usd |
CY2021 | SFST |
Operating Lease Payment
OperatingLeasePayment
|
605000 | usd |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1943000 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2026000 | usd |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1647000 | usd |
CY2023 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
3790000 | usd |
CY2022 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
2914000 | usd |
CY2021 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
13676000 | usd |
CY2023 | us-gaap |
Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
|
147040000 | usd |
CY2022 | us-gaap |
Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
|
165698000 | usd |
CY2021 | us-gaap |
Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
|
486145000 | usd |
CY2023 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
147553000 | usd |
CY2022 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
178251000 | usd |
CY2021 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
546522000 | usd |
CY2023 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
1379000 | usd |
CY2022 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
1289000 | usd |
CY2021 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
1231000 | usd |
CY2023 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
230000 | usd |
CY2022 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
22000 | usd |
CY2021 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-1589000 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
1378000 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
5047000 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-2126000 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
2178000 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
4082000 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-11302000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
17653000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
50305000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
78069000 | usd |
CY2023 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
329431000 | usd |
CY2022 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
782130000 | usd |
CY2021 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
348718000 | usd |
CY2023 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1242000 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
13950000 | usd |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
26509000 | usd |
CY2023 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
63224000 | usd |
CY2022 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
13048000 | usd |
CY2021 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
49393000 | usd |
CY2023 | us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
51642000 | usd |
CY2022 | us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
27751000 | usd |
CY2021 | us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
2250000 | usd |
CY2023 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
7928000 | usd |
CY2022 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
10833000 | usd |
CY2021 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
20673000 | usd |
CY2023 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Other Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments
|
42536000 | usd |
CY2022 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Other Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments
|
20939000 | usd |
CY2021 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Other Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments
|
1861000 | usd |
CY2023 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
16500000 | usd |
CY2022 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
12429000 | usd |
CY2021 | us-gaap |
Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
|
7500000 | usd |
CY2022 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
95000 | usd |
CY2021 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
50000 | usd |
CY2021 | us-gaap |
Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
|
1159000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-378575000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-792583000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-410627000 | usd |
CY2023 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
245700000 | usd |
CY2022 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
570038000 | usd |
CY2021 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
421068000 | usd |
CY2023 | SFST |
Decrease In Federal Home Loan Bank Advances And Other Borrowings
DecreaseInFederalHomeLoanBankAdvancesAndOtherBorrowings
|
-100000000 | usd |
CY2022 | SFST |
Decrease In Federal Home Loan Bank Advances And Other Borrowings
DecreaseInFederalHomeLoanBankAdvancesAndOtherBorrowings
|
-175000000 | usd |
CY2021 | SFST |
Decrease In Federal Home Loan Bank Advances And Other Borrowings
DecreaseInFederalHomeLoanBankAdvancesAndOtherBorrowings
|
25000000 | usd |
CY2023 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
518000 | usd |
CY2022 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
905000 | usd |
CY2021 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
3012000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
346218000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
745943000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
399080000 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-14704000 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
3665000 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
66522000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
170874000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
167209000 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
100687000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
156170000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
170874000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
167209000 | usd |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
93351000 | usd |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
18877000 | usd |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
6402000 | usd |
CY2023 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1514000 | usd |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
11828000 | usd |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
21652000 | usd |
CY2021 | SFST |
Foreclosure Of Other Real Estate
ForeclosureOfOtherRealEstate
|
367000 | usd |
CY2023 | SFST |
Unrealized Gainloss On Securities Net Of Income Taxes
UnrealizedGainlossOnSecuritiesNetOfIncomeTaxes
|
2068000 | usd |
CY2022 | SFST |
Unrealized Gainloss On Securities Net Of Income Taxes
UnrealizedGainlossOnSecuritiesNetOfIncomeTaxes
|
-12660000 | usd |
CY2021 | SFST |
Unrealized Gainloss On Securities Net Of Income Taxes
UnrealizedGainlossOnSecuritiesNetOfIncomeTaxes
|
-1765000 | usd |
CY2023 | SFST |
Operating Leases
OperatingLeases
|
145000 | usd |
CY2022 | SFST |
Operating Leases
OperatingLeases
|
595000 | usd |
CY2021 | SFST |
Operating Leases
OperatingLeases
|
10221000 | usd |
CY2023Q4 | us-gaap |
Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
|
3473000 | usd |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_845_eus-gaap--UseOfEstimates_zcQL190CUYG2" style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: justify"><span id="xdx_869_z9PxkzdBIS5h">Use of Estimates</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amount of income and expenses during the reporting periods. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for credit losses, derivatives, real estate acquired in settlement of loans, fair value of financial instruments, evaluating investment securities for credit impairment and valuation of deferred tax assets.</p> | |
CY2023 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_z43HUGA9i2c2" style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: justify"><span id="xdx_864_z7mxeCsMyTvj">Risks and Uncertainties</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify">In the normal course of its business, the Company encounters two significant types of risks: economic and regulatory. There are three main components of economic risk: interest rate risk, credit risk and market risk. The Company is subject to interest rate risk to the degree that its interest-bearing liabilities mature or reprice at different speeds, or on different bases, than its interest-earning assets. Credit risk is the risk of default within the Company’s loan portfolio that results from borrowers’ inability or unwillingness to make contractually required payments. Market risk reflects changes in the value of collateral underlying loans receivable and the valuation of real estate held by the Company. There were three significant bank failures in the first five months of 2023, primarily due to the failed banks’ lack of liquidity as depositors sought to withdraw their deposits. Due to rising interest rates, the failed banks were unable to sell investment securities held to meet liquidity needs without realizing substantial losses. As a result of the recent bank failures and in an effort to strengthen public confidence in the banking system and protect depositors, regulators announced that any losses to the Deposit Insurance Fund to support uninsured depositors will be recovered by a special assessment on banks, as required by law, which has and could continue to increase the cost of our FDIC insurance assessments. The continued impact of these bank failures on the economy, financial institutions and their depositors, as well as any governmental regulatory responses or actions resulting from the same, is difficult to predict at this time.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify">The Company is subject to the regulations of various governmental agencies. These regulations can and do change significantly from period to period. The Company also undergoes periodic examinations by the regulatory agencies, which may subject it to changes with respect to valuation of assets, amount of required credit loss allowance and operating restrictions resulting from the regulators’ judgments based on information available to them at the time of their examinations.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify">The Bank makes loans to individuals and businesses in the Upstate, Midlands, and Lowcountry regions of South Carolina as well as the Triangle, Triad and Charlotte regions of North Carolina and Atlanta, Georgia for various personal and commercial purposes. The Bank’s loan portfolio has a concentration of real estate loans. As of December 31, 2023 and 2022, real estate loans represented <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pip0_dp_c20231231_zTLN9Xlc4ed5" title="Real estate loan percentage"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pip0_dp_c20221231_zD0k3JwA845e" title="Real estate loan percentage">84.8</span></span>% of total loans. However, borrowers’ ability to repay their loans is not dependent upon any specific economic sector.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify">As of December 31, 2023, the Company’s and the Bank’s capital ratios were in excess of all regulatory requirements. While management believes that we have sufficient capital to withstand an extended economic recession, our reported and regulatory capital ratios could be adversely impacted by future credit losses.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify">The Company maintains access to multiple sources of liquidity, including a $<span id="xdx_905_eus-gaap--LineOfCreditAssumed1_pn3n3_dm_c20230101__20231231_zbXTUigO7ZC3" title="Line of credit">15</span>.0 million holding company line of credit with another bank which could be used to support capital ratios at the subsidiary bank. As of December 31, 2023, the $<span id="xdx_902_eus-gaap--LineOfCreditFacilityRemainingBorrowingCapacity_iI_pn3n3_dm_c20231231_zLa8Je5SI9Q2" title="Unused line">15</span>.0 million line was unused.</p> | |
CY2023Q4 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.848 | pure |
CY2022Q4 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.848 | pure |
CY2023 | us-gaap |
Line Of Credit Assumed1
LineOfCreditAssumed1
|
15000000 | usd |
CY2023Q4 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
15000000 | usd |
CY2023 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zUylvuVzheha" style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: justify"><span id="xdx_861_zBjGvyS1Nl95">Reclassifications</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify">Certain amounts, previously reported, have been reclassified to state all periods on a comparable basis and had no effect on shareholders’ equity or net income.</p> | |
CY2023 | us-gaap |
Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
|
1500000 | usd |
CY2023 | SFST |
Liability For Unfunded Commitments
LiabilityForUnfundedCommitments
|
2000000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Appropriated
RetainedEarningsAppropriated
|
2800000 | usd |
CY2023 | SFST |
Accrued Interest Receivable
AccruedInterestReceivable
|
530000 | usd |
CY2022 | SFST |
Accrued Interest Receivable
AccruedInterestReceivable
|
382000 | usd |
CY2023 | us-gaap |
Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
|
11600000 | usd |
CY2022 | us-gaap |
Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
|
8900000 | usd |
CY2022Q4 | us-gaap |
Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
|
1180000 | usd |
CY2023 | SFST |
Proceeds From Sale Of Investment Securities
ProceedsFromSaleOfInvestmentSecurities
|
16500000 | usd |
CY2022 | SFST |
Proceeds From Sale Of Investment Securities
ProceedsFromSaleOfInvestmentSecurities
|
12600000 | usd |
CY2022 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
83000 | usd |
CY2022 | us-gaap |
Loss On Sale Of Investments
LossOnSaleOfInvestments
|
71000 | usd |
CY2021 | SFST |
Proceeds From Sale Of Investment Securities
ProceedsFromSaleOfInvestmentSecurities
|
770000 | usd |
CY2021 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
6000 | usd |
CY2021 | us-gaap |
Loss On Sale Of Investments
LossOnSaleOfInvestments
|
9000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
9503000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
9467000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
10222000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
9279000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
9398000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
8277000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
32159000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
28380000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
24436000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
20043000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
|
97174000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
|
87576000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
|
76489000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
|
65027000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
149058000 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
134702000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
110323000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
93347000 | usd |
CY2023Q4 | SFST |
Number Of Investments In Continuous Unrealized Loss Position Less Than Twelve Month
NumberOfInvestmentsInContinuousUnrealizedLossPositionLessThanTwelveMonth
|
123 | integer |
CY2023Q4 | us-gaap |
Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
|
16063000 | usd |
CY2022Q4 | us-gaap |
Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
|
9250000 | usd |
CY2023Q4 | SFST |
Investment In Trust Preferred Securities
InvestmentInTrustPreferredSecurities
|
403000 | usd |
CY2022Q4 | SFST |
Investment In Trust Preferred Securities
InvestmentInTrustPreferredSecurities
|
403000 | usd |
CY2023Q4 | us-gaap |
Other Investments
OtherInvestments
|
19939000 | usd |
CY2022Q4 | us-gaap |
Other Investments
OtherInvestments
|
10833000 | usd |
CY2023Q4 | us-gaap |
Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
|
7200000 | usd |
CY2022Q4 | us-gaap |
Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
|
3900000 | usd |
CY2023Q4 | SFST |
Real Estate Loan Percentage Of Aggregate Loan
RealEstateLoanPercentageOfAggregateLoan
|
0.848 | pure |
CY2023Q4 | SFST |
Commercial Loans Percentage Of Aggregate Real Estate Loan
CommercialLoansPercentageOfAggregateRealEstateLoan
|
0.565 | pure |
CY2023Q4 | SFST |
Consumer Loans Percentage Of Aggregate Real Estate Loan
ConsumerLoansPercentageOfAggregateRealEstateLoan
|
0.435 | pure |
CY2023Q4 | SFST |
Occupied Loans Percentage
OccupiedLoansPercentage
|
0.175 | pure |
CY2023Q4 | us-gaap |
Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
|
7000000 | usd |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
|
7300000 | usd |
CY2023Q4 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
3602627000 | usd |
CY2023Q4 | SFST |
Loans And Leases Receivable Net Of Deferred Income Percentage
LoansAndLeasesReceivableNetOfDeferredIncomePercentage
|
1.000 | pure |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
3273363000 | usd |
CY2022Q4 | SFST |
Loans And Leases Receivable Net Of Deferred Income Percentage
LoansAndLeasesReceivableNetOfDeferredIncomePercentage
|
1.000 | pure |
CY2023Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
40682000 | usd |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
38639000 | usd |
CY2023Q4 | us-gaap |
Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
|
3561945000 | usd |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
|
3234724000 | usd |
CY2023Q4 | us-gaap |
Loans Receivable With Variable Rates Of Interest1
LoansReceivableWithVariableRatesOfInterest1
|
574352000 | usd |
CY2022Q4 | us-gaap |
Loans Receivable With Variable Rates Of Interest1
LoansReceivableWithVariableRatesOfInterest1
|
439287000 | usd |
CY2023Q4 | us-gaap |
Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
|
3028275000 | usd |
CY2022Q4 | us-gaap |
Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
|
2834076000 | usd |
CY2023Q4 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
3602627000 | usd |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
3273363000 | usd |
CY2023 | SFST |
Mortgage Loans Pledged As Collateral Advances
MortgageLoansPledgedAsCollateralAdvances
|
1250000000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
|
365276000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
|
1049553000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
|
695294000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
|
404783000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
|
234517000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
|
467546000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Revolving
FinancingReceivableRevolving
|
383458000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
|
2200000 | usd |
CY2023Q4 | us-gaap |
Notes Receivable Gross
NotesReceivableGross
|
3602627000 | usd |
CY2023 | SFST |
Current Period Gross Writeoffs2022
CurrentPeriodGrossWriteoffs2022
|
200000 | usd |
CY2023 | SFST |
Current Period Gross Writeoffs2020
CurrentPeriodGrossWriteoffs2020
|
28000 | usd |
CY2023 | SFST |
Current Period Gross Writeoffs Prior
CurrentPeriodGrossWriteoffsPrior
|
42000 | usd |
CY2023 | SFST |
Current Period Gross Writeoffs Revolving
CurrentPeriodGrossWriteoffsRevolving
|
469000 | usd |
CY2023 | SFST |
Current Period Gross Writeoffs Revolving Convert Term
CurrentPeriodGrossWriteoffsRevolvingConvertTerm
|
22000 | usd |
CY2023 | SFST |
Current Period Gross Writeoffs Total
CurrentPeriodGrossWriteoffsTotal
|
761000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
|
955802000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
|
735661000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
|
447470000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
|
257328000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
|
195538000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
|
344363000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Revolving
FinancingReceivableRevolving
|
335274000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
|
1927000 | usd |
CY2022Q4 | us-gaap |
Notes Receivable Gross
NotesReceivableGross
|
3273363000 | usd |
CY2022 | SFST |
Current Period Gross Writeoffs2022
CurrentPeriodGrossWriteoffs2022
|
91000 | usd |
CY2022 | SFST |
Current Period Gross Writeoffs2020
CurrentPeriodGrossWriteoffs2020
|
23000 | usd |
CY2022 | SFST |
Current Period Gross Writeoffs Prior
CurrentPeriodGrossWriteoffsPrior
|
32000 | usd |
CY2022 | SFST |
Current Period Gross Writeoffs Revolving
CurrentPeriodGrossWriteoffsRevolving
|
339000 | usd |
CY2022 | SFST |
Current Period Gross Writeoffs Total
CurrentPeriodGrossWriteoffsTotal
|
485000 | usd |
CY2023Q4 | SFST |
Total Loan
TotalLoan
|
3602627000 | usd |
CY2022Q4 | SFST |
Total Loan
TotalLoan
|
3273363000 | usd |
CY2023Q4 | SFST |
Part Of Loans Of Thirty Days Or More Past Due As Percentage Of Aggregate Loan Portfolio
PartOfLoansOfThirtyDaysOrMorePastDueAsPercentageOfAggregateLoanPortfolio
|
0.0037 | pure |
CY2022Q4 | SFST |
Part Of Loans Of Thirty Days Or More Past Due As Percentage Of Aggregate Loan Portfolio
PartOfLoansOfThirtyDaysOrMorePastDueAsPercentageOfAggregateLoanPortfolio
|
0.0011 | pure |
CY2023Q4 | us-gaap |
Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
|
3963000 | usd |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
|
831000 | usd |
CY2022Q4 | SFST |
Nonaccruing Td Rs
NonaccruingTDRs
|
1796000 | usd |
CY2023Q4 | SFST |
Total Nonaccrual Loans Including Nonaccruing Tdrs
TotalNonaccrualLoansIncludingNonaccruingTdrs
|
3963000 | usd |
CY2022Q4 | SFST |
Total Nonaccrual Loans Including Nonaccruing Tdrs
TotalNonaccrualLoansIncludingNonaccruingTdrs
|
2627000 | usd |
CY2023Q4 | SFST |
Total Nonperforming Assets
TotalNonperformingAssets
|
3963000 | usd |
CY2022Q4 | SFST |
Total Nonperforming Assets
TotalNonperformingAssets
|
2627000 | usd |
CY2023Q4 | SFST |
Nonperforming Assets As Percentage Of Assets
NonperformingAssetsAsPercentageOfAssets
|
0.0010 | pure |
CY2022Q4 | SFST |
Nonperforming Assets As Percentage Of Assets
NonperformingAssetsAsPercentageOfAssets
|
0.0007 | pure |
CY2023Q4 | us-gaap |
Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
|
0.0011 | pure |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
|
0.0008 | pure |
CY2023Q4 | SFST |
Total Loans Over90 Days Past Due
TotalLoansOver90DaysPastDue
|
1300000 | usd |
CY2022Q4 | SFST |
Total Loans Over90 Days Past Due
TotalLoansOver90DaysPastDue
|
402000 | usd |
CY2022Q4 | SFST |
Accruing Troubled Debt Restructurings
AccruingTroubledDebtRestructurings
|
4503000 | usd |
CY2023 | SFST |
Foregone Interest Income On Non Accrual Loan
ForegoneInterestIncomeOnNonAccrualLoan
|
73000 | usd |
CY2022 | SFST |
Foregone Interest Income On Non Accrual Loan
ForegoneInterestIncomeOnNonAccrualLoan
|
28000 | usd |
CY2022Q4 | SFST |
Total Number Of Loans
TotalNumberOfLoans
|
13 | integer |
CY2022Q4 | SFST |
Aggregate Sum Of Loans Classified As Troubled Debt Restructurings
AggregateSumOfLoansClassifiedAsTroubledDebtRestructurings
|
6300000 | usd |
CY2022Q4 | us-gaap |
Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now
InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW
|
318030000 | usd |
CY2022Q4 | SFST |
Related Allowance For Credit Losess
RelatedAllowanceForCreditLosess
|
1200000 | usd |
CY2023 | SFST |
Increase In Allowance For Credit Losses
IncreaseInAllowanceForCreditLosses
|
1500000 | usd |
CY2023 | us-gaap |
Provision For Other Credit Losses
ProvisionForOtherCreditLosses
|
2200000 | usd |
CY2023 | SFST |
Primarily Loan Growth
PrimarilyLoanGrowth
|
329300000 | usd |
CY2022 | us-gaap |
Provision For Other Credit Losses
ProvisionForOtherCreditLosses
|
5400000 | usd |
CY2022 | SFST |
Primarily Loan Growth
PrimarilyLoanGrowth
|
783500000 | usd |
CY2023Q4 | us-gaap |
Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
|
1393000 | usd |
CY2023Q4 | us-gaap |
Inventory Real Estate
InventoryRealEstate
|
1393000 | usd |
CY2022Q4 | us-gaap |
Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
|
545000 | usd |
CY2022Q4 | us-gaap |
Inventory Real Estate
InventoryRealEstate
|
545000 | usd |
CY2023Q4 | SFST |
Allowance For Credit Losses For Loan Commitments
AllowanceForCreditLossesForLoanCommitments
|
1800000 | usd |
CY2022Q4 | SFST |
Allowance For Credit Losses For Loan Commitments
AllowanceForCreditLossesForLoanCommitments
|
2800000 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
21907000 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
17219000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
72131000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
75597000 | usd |
CY2023Q4 | SFST |
Operating Lease Right Of Use Assets
OperatingLeaseRightOfUseAssets
|
22170000 | usd |
CY2022Q4 | SFST |
Operating Lease Right Of Use Assets
OperatingLeaseRightOfUseAssets
|
23586000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
94301000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
99183000 | usd |
CY2023 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4800000 | usd |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3700000 | usd |
CY2023Q4 | us-gaap |
Interest Bearing Domestic Deposit Money Market
InterestBearingDomesticDepositMoneyMarket
|
1605278000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
22200000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
23600000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
24600000 | usd |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
25800000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P5Y10M28D | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P6Y10M20D | |
CY2023Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0294 | pure |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0286 | pure |
CY2023 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
2400000 | usd |
CY2022 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
2700000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
2099000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
2157000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
2210000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
2267000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
2015000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
20187000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
30935000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
6291000 | usd |
CY2023Q4 | SFST |
Operating Lease Liability1
OperatingLeaseLiability1
|
24644000 | usd |
CY2023Q4 | us-gaap |
Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
|
674167000 | usd |
CY2022Q4 | us-gaap |
Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
|
804115000 | usd |
CY2023Q4 | us-gaap |
Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now
InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW
|
310218000 | usd |
CY2022Q4 | us-gaap |
Interest Bearing Domestic Deposit Money Market
InterestBearingDomesticDepositMoneyMarket
|
1506418000 | usd |
CY2023Q4 | us-gaap |
Interest Bearing Domestic Deposit Savings
InterestBearingDomesticDepositSavings
|
31669000 | usd |
CY2022Q4 | us-gaap |
Interest Bearing Domestic Deposit Savings
InterestBearingDomesticDepositSavings
|
40673000 | usd |
CY2023Q4 | us-gaap |
Time Deposits
TimeDeposits
|
758232000 | usd |
CY2022Q4 | us-gaap |
Time Deposits
TimeDeposits
|
464628000 | usd |
CY2023Q4 | us-gaap |
Deposits
Deposits
|
3379564000 | usd |
CY2022Q4 | us-gaap |
Deposits
Deposits
|
3133864000 | usd |
CY2023Q4 | us-gaap |
Time Deposits100000 Or More
TimeDeposits100000OrMore
|
568100000 | usd |
CY2022Q4 | us-gaap |
Time Deposits100000 Or More
TimeDeposits100000OrMore
|
374800000 | usd |
CY2023Q4 | us-gaap |
Deposits Money Market Deposits
DepositsMoneyMarketDeposits
|
379400000 | usd |
CY2022Q4 | us-gaap |
Deposits Money Market Deposits
DepositsMoneyMarketDeposits
|
236200000 | usd |
CY2023 | us-gaap |
Interest Expense Time Deposits100000 Or More
InterestExpenseTimeDeposits100000OrMore
|
23800000 | usd |
CY2022 | us-gaap |
Interest Expense Time Deposits100000 Or More
InterestExpenseTimeDeposits100000OrMore
|
3200000 | usd |
CY2021 | us-gaap |
Interest Expense Time Deposits100000 Or More
InterestExpenseTimeDeposits100000OrMore
|
786000 | usd |
CY2023Q4 | us-gaap |
Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
|
494392000 | usd |
CY2023Q4 | us-gaap |
Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
|
45190000 | usd |
CY2023Q4 | us-gaap |
Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
|
100308000 | usd |
CY2023Q4 | us-gaap |
Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
|
60000 | usd |
CY2023Q4 | us-gaap |
Time Deposit Maturities Year Five
TimeDepositMaturitiesYearFive
|
118282000 | usd |
CY2023Q4 | us-gaap |
Time Deposits
TimeDeposits
|
758232000 | usd |
CY2023Q4 | us-gaap |
Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
|
275000000 | usd |
CY2022Q4 | us-gaap |
Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
|
175000000 | usd |
CY2023Q4 | SFST |
Federal Home Loan Banks Outstanding Amount
FederalHomeLoanBanksOutstandingAmount
|
275000000 | usd |
CY2023Q4 | SFST |
Federal Home Loan Bank Advances Variable Rate
FederalHomeLoanBankAdvancesVariableRate
|
35000000.0 | usd |
CY2023Q4 | us-gaap |
Federal Home Loan Bank Advances Fixed Rate
FederalHomeLoanBankAdvancesFixedRate
|
240000000 | usd |
CY2023Q4 | SFST |
Mortgage Loans
MortgageLoans
|
1250000000 | usd |
CY2023Q4 | us-gaap |
Federal Home Loan Bank Stock
FederalHomeLoanBankStock
|
16100000 | usd |
CY2022Q4 | SFST |
Federal Home Loan Banks Outstanding Amount
FederalHomeLoanBanksOutstandingAmount
|
175000000 | usd |
CY2022Q4 | SFST |
Mortgage Loans
MortgageLoans
|
1050000000.00 | usd |
CY2022Q4 | us-gaap |
Federal Home Loan Bank Stock
FederalHomeLoanBankStock
|
9300000 | usd |
CY2023Q4 | us-gaap |
Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
|
275000000 | usd |
CY2023Q4 | us-gaap |
Federal Home Loan Bank Advances Branch Of Fhlb Bank Interest Rate
FederalHomeLoanBankAdvancesBranchOfFHLBBankInterestRate
|
0.0389 | pure |
CY2022Q4 | us-gaap |
Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
|
175000000 | usd |
CY2022Q4 | us-gaap |
Federal Home Loan Bank Advances Branch Of Fhlb Bank Interest Rate
FederalHomeLoanBankAdvancesBranchOfFHLBBankInterestRate
|
0.0457 | pure |
CY2023 | SFST |
Description Of Wall Street Reform And Consumer Protection Act
DescriptionOfWallStreetReformAndConsumerProtectionAct
|
Dodd-Frank Act prohibit institutions that had more than $15 billion in assets on December 31, 2009 from including trust preferred securities as Tier 1 capital beginning in 2013, with one-third phased out over the two years ending in 2015. Financial institutions with less than $15 billion in total assets, such as the Bank, may continue to include their trust preferred securities issued prior to May 19, 2010 in Tier 1 capital, but cannot include in Tier 1 capital trust preferred securities issued after such date. | |
CY2023 | us-gaap |
Debt Instrument Term
DebtInstrumentTerm
|
P10Y | |
CY2023Q4 | us-gaap |
Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
|
0.0475 | pure |
CY2023Q4 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
108500000 | usd |
CY2023Q4 | SFST |
Additional Borrowings Under Federal Home Loan
AdditionalBorrowingsUnderFederalHomeLoan
|
542800000 | usd |
CY2023Q4 | SFST |
Pledged Amount
PledgedAmount
|
227100000 | usd |
CY2023 | us-gaap |
Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
|
15000000 | usd |
CY2023 | SFST |
U.S.Prime Ratepluspercentage
U.S.PrimeRatepluspercentage
|
0.0025 | pure |
CY2023 | us-gaap |
Gain Loss On Fair Value Hedge Ineffectiveness Net
GainLossOnFairValueHedgeIneffectivenessNet
|
-482000 | usd |
CY2023 | SFST |
Fair Value Derivative Designated As Hedging Instrument
FairValueDerivativeDesignatedAsHedgingInstrument
|
511000 | usd |
CY2023 | us-gaap |
Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
|
29000 | usd |
CY2023 | SFST |
Percentage Of Loans Collateral By Real Estate
PercentageOfLoansCollateralByRealEstate
|
0.85 | pure |
CY2023 | SFST |
Fair Value Of Measurements Valuation Techniques
FairValueOfMeasurementsValuationTechniques
|
Appraised Value/ Discounted Cash Flows | |
CY2023 | SFST |
Fair Value Of Measurements Significant Assumptions
FairValueOfMeasurementsSignificantAssumptions
|
Discounts to appraisals or cash flows for estimated holding and/or selling costs or age of appraisal | |
CY2023Q4 | us-gaap |
Other Investments
OtherInvestments
|
19939000 | usd |
CY2023Q4 | us-gaap |
Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
|
19939000 | usd |
CY2023Q4 | SFST |
Loans Receivable Carrying Amount
LoansReceivableCarryingAmount
|
3557120000 | usd |
CY2023Q4 | us-gaap |
Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
|
3337768000 | usd |
CY2023Q4 | SFST |
Deposits Carrying Amount
DepositsCarryingAmount
|
3379564000 | usd |
CY2023Q4 | us-gaap |
Deposits Fair Value Disclosure
DepositsFairValueDisclosure
|
2961182000 | usd |
CY2023Q4 | us-gaap |
Federal Home Loan Bank Advances
FederalHomeLoanBankAdvances
|
36322000 | usd |
CY2023Q4 | us-gaap |
Fair Value Liabilities Measured On Recurring Basis Subordinated Debt Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations
|
40712000 | usd |
CY2022Q4 | us-gaap |
Other Investments
OtherInvestments
|
10833000 | usd |
CY2022Q4 | us-gaap |
Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
|
10833000 | usd |
CY2022Q4 | SFST |
Loans Receivable Carrying Amount
LoansReceivableCarryingAmount
|
3227455000 | usd |
CY2022Q4 | us-gaap |
Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
|
3057891000 | usd |
CY2022Q4 | SFST |
Deposits Carrying Amount
DepositsCarryingAmount
|
3133864000 | usd |
CY2022Q4 | us-gaap |
Deposits Fair Value Disclosure
DepositsFairValueDisclosure
|
2717900000 | usd |
CY2022Q4 | us-gaap |
Federal Home Loan Bank Advances
FederalHomeLoanBankAdvances
|
36214000 | usd |
CY2022Q4 | us-gaap |
Fair Value Liabilities Measured On Recurring Basis Subordinated Debt Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations
|
39885000 | usd |
CY2023 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
269072 | shares |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
131433 | shares |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9000 | shares |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
13426000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
29115000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
46711000 | usd |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
13426000 | usd |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
29115000 | usd |
CY2021 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
46711000 | usd |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
8046633 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7958294 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7843692 | shares |
CY2023 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
31821 | shares |
CY2022 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
113396 | shares |
CY2021 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
145288 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
8078454 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
8071690 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7988980 | shares |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.67 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
3.66 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
5.96 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.66 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
3.61 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
5.85 | |
CY2023 | SFST |
Period Of Employment Agreement
PeriodOfEmploymentAgreement
|
P2Y | |
CY2023 | SFST |
Number Of Executive Officers
NumberOfExecutiveOfficers
|
13 | integer |
CY2023 | SFST |
Employment Agreement Description
EmploymentAgreementDescription
|
These agreements also include a) an incentive program, b) a stock option plan, c) a one-year non-compete agreement upon termination and a severance payment equal to one year of compensation. | |
CY2023Q4 | SFST |
Agreegate Commitment Amount
AgreegateCommitmentAmount
|
4200000 | usd |
CY2023Q4 | SFST |
Approximately Commitments Totaled
ApproximatelyCommitmentsTotaled
|
1400000 | usd |
CY2023 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
3769000 | usd |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
8482000 | usd |
CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
10414000 | usd |
CY2023 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
460000 | usd |
CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1273000 | usd |
CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
2088000 | usd |
CY2023 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
4229000 | usd |
CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
9755000 | usd |
CY2021 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
12502000 | usd |
CY2023 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-228000 | usd |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-757000 | usd |
CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
1590000 | usd |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4001000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8998000 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
14092000 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
3660000 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
8004000 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
12768000 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
364000 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
1006000 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
1649000 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
|
-7000 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
|
27000 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
|
43000 | usd |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
133000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
42000 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
-115000 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-163000 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-27000 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-167000 | usd |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4001000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8998000 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
14092000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
|
8543000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
|
8114000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
384000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
584000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
|
3015000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
|
3565000 | usd |
CY2023Q4 | SFST |
Deferred Tax Assets Net Deferred Loan Fees
DeferredTaxAssetsNetDeferredLoanFees
|
1475000 | usd |
CY2022Q4 | SFST |
Deferred Tax Assets Net Deferred Loan Fees
DeferredTaxAssetsNetDeferredLoanFees
|
1537000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
1458000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
1762000 | usd |
CY2023Q4 | SFST |
Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
|
5175000 | usd |
CY2022Q4 | SFST |
Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
|
5424000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
479000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
393000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
20529000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
21379000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
3334000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
3561000 | usd |
CY2023Q4 | SFST |
Deferred Tax Liabilities Hedging Transactions
DeferredTaxLiabilitiesHedgingTransactions
|
74000 | usd |
CY2022Q4 | SFST |
Deferred Tax Liabilities Hedging Transactions
DeferredTaxLiabilitiesHedgingTransactions
|
27000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
255000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
316000 | usd |
CY2023Q4 | SFST |
Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
|
4656000 | usd |
CY2022Q4 | SFST |
Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
|
4953000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
10000 | usd |
CY2023Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
8329000 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
8857000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
12200000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
12522000 | usd |
CY2022Q4 | SFST |
Loan Transactions With Related Party
LoanTransactionsWithRelatedParty
|
17217000 | usd |
CY2021Q4 | SFST |
Loan Transactions With Related Party
LoanTransactionsWithRelatedParty
|
8790000 | usd |
CY2023 | SFST |
New Loans
NewLoans
|
17455000 | usd |
CY2022 | SFST |
New Loans
NewLoans
|
21010000 | usd |
CY2023 | SFST |
Loan Payments Related Party
LoanPaymentsRelatedParty
|
-9420000 | usd |
CY2022 | SFST |
Loan Payments Related Party
LoanPaymentsRelatedParty
|
-12583000 | usd |
CY2023Q4 | SFST |
Loan Transactions With Related Party
LoanTransactionsWithRelatedParty
|
25252000 | usd |
CY2022Q4 | SFST |
Loan Transactions With Related Party
LoanTransactionsWithRelatedParty
|
17217000 | usd |
CY2023 | us-gaap |
Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
|
9120 | usd |
CY2023 | us-gaap |
Payments For Rent
PaymentsForRent
|
88000 | usd |
CY2022 | us-gaap |
Payments For Rent
PaymentsForRent
|
79000 | usd |
CY2022 | us-gaap |
Payments For Tenant Improvements
PaymentsForTenantImprovements
|
86000 | usd |
CY2023Q4 | us-gaap |
Unused Commitments To Extend Credit
UnusedCommitmentsToExtendCredit
|
724600000 | usd |
CY2023 | us-gaap |
Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
|
145600000 | usd |
CY2023 | us-gaap |
Loans And Leases Receivable Commitments Variable Rates
LoansAndLeasesReceivableCommitmentsVariableRates
|
579000000.0 | usd |
CY2022Q4 | us-gaap |
Unused Commitments To Extend Credit
UnusedCommitmentsToExtendCredit
|
878300000 | usd |
CY2022 | us-gaap |
Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
|
318900000 | usd |
CY2022 | us-gaap |
Loans And Leases Receivable Commitments Variable Rates
LoansAndLeasesReceivableCommitmentsVariableRates
|
559400000 | usd |
CY2023Q4 | us-gaap |
Other Commitment
OtherCommitment
|
16100000 | usd |
CY2022Q4 | us-gaap |
Other Commitment
OtherCommitment
|
14300000 | usd |
CY2023 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
528000 | usd |
CY2022 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
927000 | usd |
CY2021 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
1148000 | usd |
CY2023 | SFST |
Amortization Of Deferred Compensation On Restricted Stock
AmortizationOfDeferredCompensationOnRestrictedStock
|
1415000 | usd |
CY2022 | SFST |
Amortization Of Deferred Compensation On Restricted Stock
AmortizationOfDeferredCompensationOnRestrictedStock
|
1099000 | usd |
CY2021 | SFST |
Amortization Of Deferred Compensation On Restricted Stock
AmortizationOfDeferredCompensationOnRestrictedStock
|
499000 | usd |
CY2023 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
1943000 | usd |
CY2022 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
2026000 | usd |
CY2021 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
1647000 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
427224 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
34.32 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
464724 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
33.97 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
495195 | shares |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
29.93 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
121000 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
40.45 | |
CY2023 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
27250 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
20.18 | |
CY2022 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
32375 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
27.94 | |
CY2021 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
127871 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
23.56 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
68625 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
34.15 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
5125 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
43.14 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
23600 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
38.88 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
331349 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
35.51 | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y10M24D | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
427224 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
34.32 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y8M12D | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
464724 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
33.97 | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y7M6D | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
267376 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
34.48 | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P4Y6M | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
287902 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
32.35 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P4Y9M18D | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
239340 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
29.68 | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
16.40 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
319058 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
370824 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
422550 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
331349 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
427224 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
267376 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
287902 | shares |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P7Y | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.3848 | pure |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0074 | pure |
CY2023Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
408000 | usd |
CY2023 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y1M6D | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
846000 | usd |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1100000 | usd |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1100000 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
80337 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
52.53 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
41699 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
44.71 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
26099 | shares |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
38.05 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
69880 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
37.12 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
53376 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
56.25 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
26450 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
48.56 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
21695 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
48.95 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
14213 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
43.26 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
9600 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
38.03 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
18989 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
46.83 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
525 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
61.14 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
1250 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
38.56 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
109533 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
44.40 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
80337 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
52.53 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
41699 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
44.71 | |
CY2023 | us-gaap |
Description Of Capital Requirements On Trust Assets
DescriptionOfCapitalRequirementsOnTrustAssets
|
The capital rules require banks and bank holding companies to maintain a minimum total risked-based capital ratio of at least 8%, a total Tier 1 capital ratio of at least 6%, a minimum common equity Tier 1 capital ratio of at least 4.5%, and a leverage ratio of at least 4%. Bank holding companies and banks are also required to hold a capital conservation buffer of common equity Tier 1 capital of 2.5% to avoid limitations on capital distributions and discretionary executive compensation payments. The capital conservation buffer was phased in incrementally over time, becoming fully effective on January 1, 2019, and consists of an additional amount of common equity equal to 2.5% of risk-weighted assets. |